TY - JOUR
T1 - BASELINE PREVALENCE AND FACTORS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE IN TWO RHEUMATOID ARTHRITIS INCEPTION COHORTS IN THE UK
AU - Dacheva, R.
AU - Busby, A.
AU - Kiely, P.
AU - Young, A.
AU - Walsh, D.
AU - Mcwilliams, D.
AU - Galloway, J.
AU - Nikiphorou, E.
N1 - © 2023, The Author(s). Published by BMJ Publishing Group Ltd. on behalf of European Alliance of Associations for Rheumatology, EULAR.
PY - 2025/1/2
Y1 - 2025/1/2
N2 - Background
Rheumatoid arthritis (RA) is a chronic, inflammatory disease with interstitial lung disease (ILD) being an important extra-articular manifestation, associated with significant morbidity and mortality.
Objectives
To determine the prevalence of ILD at time of RA diagnosis and identify baseline independent factors associated with ILD.
Methods
Two early inception cohorts (1986-2001) were used: the early RA network (ERAN) and the early RA study (ERAS). Socio-demographic, clinical and laboratory measures were recorded at baseline, 6 months and yearly thereafter. Baseline variables collected and included in analyses were: seropositivity, body mass index (BMI), ethnicity, measures of deprivation, smoking status. Comorbidity burden was evaluated using the rheumatic disease comorbidity index (RDCI). Baseline prevalence (proportion of individuals with ILD at baseline) and 95% confidence interval was estimated. Multivariable regression analyses were performed to identify risk factors at baseline associated with RA-ILD development. Multiple imputation was used for missing data.
Results
Data from a total of 2701 patients were included in the study, from whom 101 patients were diagnosed with ILD. Follow up was up to 25 years (mean 6.8 years); 75% of patients followed for ≥10 years. Of these, 12% had ILD at baseline; 46% were diagnosed with ILD during follow up and 43% were diagnosed with ILD post-mortem. The estimated prevalence of ILD at baseline was 0.44% (95% CI 0.19% to 0.69%). Univariable analyses of baseline factors showed age at onset (p
AB - Background
Rheumatoid arthritis (RA) is a chronic, inflammatory disease with interstitial lung disease (ILD) being an important extra-articular manifestation, associated with significant morbidity and mortality.
Objectives
To determine the prevalence of ILD at time of RA diagnosis and identify baseline independent factors associated with ILD.
Methods
Two early inception cohorts (1986-2001) were used: the early RA network (ERAN) and the early RA study (ERAS). Socio-demographic, clinical and laboratory measures were recorded at baseline, 6 months and yearly thereafter. Baseline variables collected and included in analyses were: seropositivity, body mass index (BMI), ethnicity, measures of deprivation, smoking status. Comorbidity burden was evaluated using the rheumatic disease comorbidity index (RDCI). Baseline prevalence (proportion of individuals with ILD at baseline) and 95% confidence interval was estimated. Multivariable regression analyses were performed to identify risk factors at baseline associated with RA-ILD development. Multiple imputation was used for missing data.
Results
Data from a total of 2701 patients were included in the study, from whom 101 patients were diagnosed with ILD. Follow up was up to 25 years (mean 6.8 years); 75% of patients followed for ≥10 years. Of these, 12% had ILD at baseline; 46% were diagnosed with ILD during follow up and 43% were diagnosed with ILD post-mortem. The estimated prevalence of ILD at baseline was 0.44% (95% CI 0.19% to 0.69%). Univariable analyses of baseline factors showed age at onset (p
U2 - 10.1136/annrheumdis-2023-eular.4121
DO - 10.1136/annrheumdis-2023-eular.4121
M3 - Meeting abstract
SN - 0003-4967
VL - 82
SP - 483
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - Suppl 1
M1 - POS0453
ER -